Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX) has secured market approval for its orthopaedic products in Singapore and Vietnam and has obtained regulatory clearance from Singapore’s Health Sciences Authority and Vietnam’s Department of Medical Equipment and Construction https://app.sharelinktechnologies.com/announcement/asx/9720d721aecbbeb12f2a5f8ebc617816
DY6
0.135
92.9%
EEL
0.001
-50%
LKY
0.042
82.6%
HCF
0.02
-44.4%
DTR
0.036
63.6%
DTM
0.003
-40%
DES
0.165
57.1%
MTB
0.003
-40%
HRE
0.029
52.6%
DYM
0.215
-34.8%
TMK
0.003
50%
JAV
0.002
-33.3%
WCN
0.034
47.8%
MIO
0.018
-33.3%
AZL
0.01
42.9%
VFX
0.002
-33.3%
YAR
0.007
40%
ANX
0.007
-30%
VRX
0.057
39%
IFG
0.005
-28.6%
WJL
0.895
37.7%
HLS
1.155
-26.2%
CMD
0.022
37.5%
XPN
0.015
-25%
VRL
0.022
37.5%
C29
0.035
-23.9%
BCB
0.475
33.8%
BB1
0.32
-21%
CRB
0.004
33.3%
1AD
0.004
-20%
GGE
0.004
33.3%
AVE
0.004
-20%
OSL
0.004
33.3%
PUR
0.037
-19.6%
PPY
0.012
33.3%
OPL
0.021
-19.2%
THB
0.012
33.3%
NWM
0.013
-18.8%
VEN
0.004
33.3%
EV1
0.009
-18.2%
